Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus

NCT01406717 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries Limited as lead sponsor.

NCT NCT01406717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01406717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
Lead sponsor
Sun Pharmaceutical Industries Limited
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2013
Completion date
November 4, 2015
Enrollment
360 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus